Sequential studies of pre-S2 antigenemia and anti-pre-S2 antibodies in relation to viral replication in acute hepatitis B followed from the early incubation phase

J Med Virol. 1988 Feb;24(2):205-9. doi: 10.1002/jmv.1890240210.

Abstract

To determine the time sequence of expression of pre-S2 peptide (120-150) during the presymptomatic phase of acute hepatitis B, we used a monoclonal antibody radioimmunoassay in five subjects followed from 30 to 70 days before the onset of liver damage. Pre-S2 peptide was present in serum at low levels from the early incubation phase and started to increase immediately after the first detection of HBV-DNA in serum, in parallel with the increase in HBsAg levels. During the symptomatic phase, levels of pre-S2 peptide declined rapidly; it was no longer detectable after recovery. Anti-pre-S2 antibodies were detected, in four patients, only in the recovery phase. These results demonstrate that expression of pre-S2 peptide occurs very early in the incubation phase of acute HBV infection and is cleared in parallel with HBsAg. Anti-pre-S2 antibodies seem to play no role in viral clearance in these patients.

MeSH terms

  • Adolescent
  • Adult
  • Female
  • Hepatitis B / etiology
  • Hepatitis B / immunology*
  • Hepatitis B / microbiology
  • Hepatitis B Antibodies / analysis*
  • Hepatitis B Surface Antigens / analysis*
  • Hepatitis B Surface Antigens / immunology
  • Hepatitis B e Antigens / analysis
  • Hepatitis B virus / immunology
  • Hepatitis B virus / physiology
  • Humans
  • Male
  • Protein Precursors / analysis*
  • Protein Precursors / immunology
  • Time Factors
  • Virus Replication

Substances

  • Hepatitis B Antibodies
  • Hepatitis B Surface Antigens
  • Hepatitis B e Antigens
  • Protein Precursors
  • presurface protein 2, hepatitis B surface antigen